Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).

被引：1
|
作者：
Balar, A. V.
Milowsky, M. I.
Apolo, A. B.
Ostrovnaya, I.
Iasonos, A.
Trout, A.
Regazzi, A. M.
Garcia-Grossman, I. R.
Gallagher, D. J.
Bajorin, D. F.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4566
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of sunitinib in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
    Gallagher, D. J.
    Milowsky, M. I.
    Gerst, S. R.
    Lasonos, A.
    Boyle, M.
    Riches, J.
    Bajorin, D. B.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 304 - 304
  • [22] Phase II study of sunitinib in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
    Gallagher, D. J.
    Milowsky, M. I.
    Gerst, S. R.
    Iasonos, A.
    Riches, J.
    Boyle, M. G.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Ajjai Alva
    Stephanie Daignault
    David C. Smith
    Maha Hussain
    [J]. Investigational New Drugs, 2014, 32 : 188 - 194
  • [24] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Alva, Ajjai
    Daignault, Stephanie
    Smith, David C.
    Hussain, Maha
    [J]. INVESTIGATIONAL NEW DRUGS, 2014, 32 (01) : 188 - 194
  • [25] Randomized phase II trial of maintenance sunitinib versus placebo following response to chemotherapy (CT) for patients (pts) with advanced urothelial carcinoma (UC)
    Grivas, Petros
    Nanus, David M.
    Stadler, Walter Michael
    Daignault, Stephanie
    Dreicer, Robert
    Kohli, Manish
    Petrylak, Daniel Peter
    Vaughn, David J.
    Bylow, Kathryn A.
    Belldegrun, Arie S.
    Sottnik, Joseph L.
    Keller, Evan T.
    Smith, David C.
    Hussain, Maha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [26] Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial
    CC Zielinski
    B Schnack
    M Grbovic
    T Brodowicz
    C Wiltschke
    G Steger
    H Pflüger
    M Marberger
    [J]. British Journal of Cancer, 1998, 78 : 370 - 374
  • [27] Paclitaxel and carboplatin in patients with metastatic urothelial cancer:: Results of a phase II trial
    Zielinski, CC
    Schnack, B
    Grbovic, M
    Brodowicz, T
    Wiltschke, C
    Steger, G
    Pflüger, H
    Marberger, M
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (03) : 370 - 374
  • [28] Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
    Bi, Feng
    Li, Han-Zhong
    Zhu, Shaoxing
    Zou, Qing
    Tang, Jia
    Zhang, Wei
    Ye, Dingwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Oberg, A. L.
    Foster, N. R.
    Jaslowski, A.
    Flynn, P. J.
    Campbell, D.
    Hedrick, E.
    Gray, L.
    Grothey, A.
    Alberts, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
    Kaufman, D
    Raghavan, D
    Carducci, M
    Levine, EG
    Murphy, B
    Aisner, J
    Kuzel, T
    Nicol, S
    Oh, W
    Stadler, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1921 - 1927
12345